Provided by Tiger Trade Technology Pte. Ltd.

Addex Therapeutics Ltd

5.89
0.0000
Post-market: 5.890.00000.00%16:04 EDT
Volume:207
Turnover:1K
Market Cap:7.45M
PE:-0.63
High:5.96
Open:5.96
Low:5.96
Close:5.89
52wk High:12.05
52wk Low:5.41
Shares:1.27M
Float Shares:1.08M
Volume Ratio:0.28
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.2717
EPS(LYR):-9.4830
ROE:-122.28%
ROA:-23.59%
PB:1.86
PE(LYR):-0.62

Loading ...

Addex Therapeutics announces publication of new ADX71743 preclinical research

TIPRANKS
·
Jul 08

Press Release: Addex Announces Publication of Research Highlighting Therapeutic Potential of Mglu7 Modulation in Regulating Sleep and Wakefulness

Dow Jones
·
Jul 08

Press Release: Addex Shareholders Approve All Resolutions at Annual General Meeting

Dow Jones
·
Jun 30

Addex Therapeutics Reports Q1 2026 Net Loss Of CHF 1.71M Versus CHF 1.47M A Year Ago, Cash CHF 0.9M

Benzinga
·
Jun 25

Press Release: Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Jun 25

Press Release: Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026

Dow Jones
·
Jun 22

Press Release: Addex Convenes Annual General Meeting 2026

Dow Jones
·
Jun 05

Addex Closes 2025 With CHF 6.7M Net Loss And CHF 1.6M Cash, Regains ADX71149 Rights And Invests In Stalicla

Benzinga
·
Apr 30

Press Release: Addex Reports Full Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Apr 30

Addex Therapeutics announces GABAB PAM candidate data

TIPRANKS
·
Apr 29

Press Release: Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model

Dow Jones
·
Apr 29

Addex Therapeutics says spin-out company to complete NTX-253 study in Q2

TIPRANKS
·
Apr 23

Press Release: Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026

Dow Jones
·
Apr 23

Press Release: Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model

Dow Jones
·
Apr 21

Addex Therapeutics Ltd – ADR trading resumes

TIPRANKS
·
Mar 19

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:56 AM

Reuters
·
Mar 18

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:58 AM

Reuters
·
Mar 11

Addex publishes negative allosteric modulators data in Molecular Psychiatry

TIPRANKS
·
Feb 03

Press Release: Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment

Dow Jones
·
Feb 03